Home › Teva Advances Most in Three Weeks on FDA Panel: Tel Aviv Mover
 

Keywords :   


Teva Advances Most in Three Weeks on FDA Panel: Tel Aviv Mover

2013-06-10 05:07:15| Biotech - Topix.net

Teva Pharmaceutical Industries Ltd., the world's largest maker of generic drugs, advanced the most in three weeks on prospects the drugmaker will begin selling its generic diabetes pill in the U.S. Shares of the Petach Tikva, Israel-based company gained 2.2 percent, the most since May 16, to 142.2 shekels, or $39.41, at the close in Tel Aviv, ... (more)

Tags: tel weeks panel advances

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Milton Public Advisory Number 5A
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Atlantic Tropical Weather Outlook
06.10Eastern North Pacific Tropical Weather Outlook
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
More »